RxISK

Making Medicines Safer for All of Us

Antidepressants

Listening to Parents

5 Comments

Anonymous When you lose a child or a partner from a rare illness, everyone is supportive, no-one denies you. They listen. But if a child dies from suicide or a complication of treatment with a drug especially a psychotropic drug no-one listens. Our culture has no place for this kind of death. They say maybe it’s for the best. He’d never have been able to face the life he’d … [Read more...] about Listening to Parents

Driven To Drink: Antidepressants and Cravings for Alcohol

267 Comments

Author: Anne-Marie (This story was first posted on davidhealy.org. It has been the most commented on post there. It epitomizes what RxISK.org is all about - one woman getting to grips with a problem she has on treatment.) I have been asked to write this story to raise awareness about a strange side effect of treatment and my efforts to get to the bottom of it. Before … [Read more...] about Driven To Drink: Antidepressants and Cravings for Alcohol

Night of the Living Cymbalta: B’s Story

103 Comments

I myself had been on and off a long series of antidepressants, but never had really dramatic withdrawal symptoms until I stopped the SNRI inhibitor Cymbalta. It started when I tried to step down from 120 mg per day, back to the standard 60 mg dose. From simply feeling depressed and tired, I shifted into full meltdown mode: crying uncontrollably; unable to concentrate; … [Read more...] about Night of the Living Cymbalta: B’s Story

Gambling on the Side Effects of Antidepressants: Does Pfizer Play Dice?

38 Comments

This piece by Daniel O'Sullivan was first posted on Crikey.com. Our interest was stimulated by a query to RxISK from Daniel who had been told by the Australian regulator (the TGA) that they only had one report of this. Looking for gambling in RxISK, gives 1 case in Australia, but 4 cases of pathological gambling - more than from all the rest of the world combined, and 8 cases … [Read more...] about Gambling on the Side Effects of Antidepressants: Does Pfizer Play Dice?